 |
PDBsum entry 2f83
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Mol Biol
13:557-558
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the factor XI zymogen reveals a pathway for transactivation.
|
|
E.Papagrigoriou,
P.A.McEwan,
P.N.Walsh,
J.Emsley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Factor XI (FXI), a coagulation protein essential to normal hemostasis,
circulates as a disulfide-linked dimer. Here we report the full-length FXI
zymogen crystal structure, revealing that the protease and four apple domains
assemble into a unique 'cup and saucer' architecture. The structure shows that
the thrombin and platelet glycoprotein Ib binding sites are remote within the
monomer but lie in close proximity across the dimer, suggesting a
transactivation mechanism.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. FXI structure. (a) Topology of the four apple
domains is represented with the protease domain removed.
Connecting loops are colored black and the loop after A4, which
leads to the C-terminal protease domain, is colored dark blue.
(b) Topology of the FXI dimer with the protease domain colored
red and Cys321 disulfide located centrally. (c) Two close-up
views of the A4 dimer interface related by a 90° rotation.
Left, interacting side chains from one side of the dimer
interface are colored yellow, making contact with a
charge-surface representation of the other half of the interface
(blue, positive; red, negative). Right, a ribbon diagram shows a
rotated view of the A4 dimer with hydrogen bonds and
electrostatic interactions colored orange.
|
 |
Figure 2.
Figure 2. FXI activation. (a) Ribbon diagrams representing
zymogen activation by superposition of the FXIa structure
(green; PDB entry 1ZJD) and the zymogen protease domain
(yellow). The region of largest conformation change is the
activation loop comprising residues 376–370. Ile370 side chain
is colored purple in both structures. Active site Ser557 side
chain is also shown. (b) Space-filling representation of the FXI
dimer. White side chains, Arg369 and Ile370 from the activation
loop; blue side chain, Lys252 and Lys253; red side chain, Glu66.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Mol Biol
(2006,
13,
557-558)
copyright 2006.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Woodruff,
B.Sullenger,
and
R.C.Becker
(2010).
Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?
|
| |
Curr Cardiol Rep,
12,
315-320.
|
 |
|
|
|
|
 |
D.Gailani,
M.F.Sun,
Q.Cheng,
A.Matafonov,
E.I.Tucker,
A.Gruber,
and
J.Emsley
(2010).
Evidence against a protein in plasma that is a product of a factor XI mRNA splice variant missing exons 6 and 7.
|
| |
Blood,
116,
1185.
|
 |
|
|
|
|
 |
J.Emsley,
P.A.McEwan,
and
D.Gailani
(2010).
Structure and function of factor XI.
|
| |
Blood,
115,
2569-2577.
|
 |
|
|
|
|
 |
R.Asselta,
V.Rimoldi,
I.Guella,
G.Soldà,
R.De Cristofaro,
F.Peyvandi,
and
S.Duga
(2010).
Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA.
|
| |
Blood,
115,
2065-2072.
|
 |
|
|
|
|
 |
D.Gailani,
and
S.B.Smith
(2009).
Structural and functional features of factor XI.
|
| |
J Thromb Haemost,
7,
75-78.
|
 |
|
|
|
|
 |
A.E.Schmidt,
M.F.Sun,
T.Ogawa,
S.P.Bajaj,
and
D.Gailani
(2008).
Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.
|
| |
Biochemistry,
47,
1326-1335.
|
 |
|
|
|
|
 |
E.de Raucourt,
P.de Mazancourt,
and
F.Quélin
(2008).
Four novel FXI gene mutations in three factor XI- deficient patients.
|
| |
Blood Coagul Fibrinolysis,
19,
240-242.
|
 |
|
|
|
|
 |
M.B.Ponczek,
D.Gailani,
and
R.F.Doolittle
(2008).
Evolution of the contact phase of vertebrate blood coagulation.
|
| |
J Thromb Haemost,
6,
1876-1883.
|
 |
|
|
|
|
 |
S.B.Smith,
and
D.Gailani
(2008).
Update on the physiology and pathology of factor IX activation by factor XIa.
|
| |
Expert Rev Hematol,
1,
87-98.
|
 |
|
|
|
|
 |
W.Wu,
D.Sinha,
S.Shikov,
C.K.Yip,
T.Walz,
P.C.Billings,
J.D.Lear,
and
P.N.Walsh
(2008).
Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.
|
| |
J Biol Chem,
283,
18655-18664.
|
 |
|
|
|
|
 |
C.Bozzao,
V.Rimoldi,
R.Asselta,
M.Landau,
R.Ghiotto,
M.L.Tenchini,
R.De Cristofaro,
G.Castaman,
and
S.Duga
(2007).
A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
|
| |
FEBS J,
274,
6128-6138.
|
 |
|
|
|
|
 |
D.Samuel,
H.Cheng,
P.W.Riley,
A.A.Canutescu,
C.Nagaswami,
J.W.Weisel,
Z.Bu,
P.N.Walsh,
and
H.Roder
(2007).
Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation.
|
| |
Proc Natl Acad Sci U S A,
104,
15693-15698.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Hooley,
P.A.McEwan,
and
J.Emsley
(2007).
Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
|
| |
J Thromb Haemost,
5,
2461-2466.
|
 |
|
|
|
|
 |
I.Botos,
and
A.Wlodawer
(2007).
The expanding diversity of serine hydrolases.
|
| |
Curr Opin Struct Biol,
17,
683-690.
|
 |
|
|
|
|
 |
P.Brennwald,
and
G.Rossi
(2007).
Spatial regulation of exocytosis and cell polarity: yeast as a model for animal cells.
|
| |
FEBS Lett,
581,
2119-2124.
|
 |
|
|
|
|
 |
P.W.Riley,
H.Cheng,
D.Samuel,
H.Roder,
and
P.N.Walsh
(2007).
Dimer dissociation and unfolding mechanism of coagulation factor XI apple 4 domain: spectroscopic and mutational analysis.
|
| |
J Mol Biol,
367,
558-573.
|
 |
|
|
|
|
 |
T.N.Miller,
D.Sinha,
T.R.Baird,
and
P.N.Walsh
(2007).
A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.
|
| |
Biochemistry,
46,
14450-14460.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |